Form D — Angelis Oncology, Inc.
0002146896-26-000001 · filed Jul 23, 2026
Offering
- Industry
- Biotechnology
- Exemptions
- 06b
- Total offering
- —
- Total sold
- $400,000
- Minimum investment
- $0
- Investors
- —
- Sales commission
- —
- Finders' fees
- —
Issuer
- Name
- Angelis Oncology, Inc.
- CIK
- 2146896
- Entity
- Corporation
- Jurisdiction
- DELAWARE
- Year incorporated
- 2026
- Address
- 211 BELGRAVE AVE.
SAN FRANCISCO, CA 94117 - Phone
- 415-215-5586
Related persons
May not be accurate — issuers self-report this list and the SEC does not verify it. Cross-check the original SEC EDGAR filing if accuracy matters.
-
Daniel Santi · Executive OfficerSan Francisco, CA Find on LinkedIn ↗
View the original filing on SEC EDGAR ↗